yusimry

Generic: adalimumab-aqvh

Labeler: coherus biosciences inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name yusimry
Generic Name adalimumab-aqvh
Labeler coherus biosciences inc
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

adalimumab 40 mg/.8mL

Manufacturer
Coherus BioSciences Inc

Identifiers & Regulatory

Product NDC 70114-210
Product ID 70114-210_92fff88b-7e54-47b3-92ed-e57bbb9b6a84
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761216
Listing Expiration 2026-12-31
Marketing Start 2023-07-01

Pharmacologic Class

Established (EPC)
tumor necrosis factor blocker [epc]
Mechanism of Action
tumor necrosis factor receptor blocking activity [moa]
Chemical Structure
antibodies, monoclonal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70114210
Hyphenated Format 70114-210

Supplemental Identifiers

RxCUI
2640389 2640395 2640397 2640400
UNII
FYS6T7F842
NUI
N0000175610 N0000175451 M0001357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name yusimry (source: ndc)
Generic Name adalimumab-aqvh (source: ndc)
Application Number BLA761216 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/.8mL
source: ndc
Packaging
  • 2 SYRINGE, GLASS in 1 CARTON (70114-210-02) / .8 mL in 1 SYRINGE, GLASS
source: ndc

Packages (1)

Ingredients (1)

adalimumab (40 mg/.8mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "92fff88b-7e54-47b3-92ed-e57bbb9b6a84", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "unii": ["FYS6T7F842"], "rxcui": ["2640389", "2640395", "2640397", "2640400"], "spl_set_id": ["cd0e7af2-7704-49ce-bde9-f645294b6788"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Coherus BioSciences Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (70114-210-02)  / .8 mL in 1 SYRINGE, GLASS", "package_ndc": "70114-210-02", "marketing_start_date": "20230701"}], "brand_name": "YUSIMRY", "product_id": "70114-210_92fff88b-7e54-47b3-92ed-e57bbb9b6a84", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "70114-210", "generic_name": "adalimumab-aqvh", "labeler_name": "Coherus BioSciences Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "YUSIMRY", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.8mL"}], "application_number": "BLA761216", "marketing_category": "BLA", "marketing_start_date": "20230701", "listing_expiration_date": "20261231"}